PE randomised controlled trial (RCT) demonstrated a significant correlation between real-world, daily step-based activity as ...

Surmodics has announced that it has acquired the business of Alta Biomed, a medical device coating and testing services ...

Shape Memory Medical has announced that Brazil’s national health surveillance agency, ANVISA (Agência Nacional de Vigilância Sanitária), has granted authorization for the Impede embolisation plug, the ...

Penumbra has announced results from a subset analysis of the landmark STORM-PE randomised controlled trial (RCT), the first ...

Among patients with femoropopliteal artery disease and no tissue loss, angioplasty with the MagicTouch PTA sirolimus-coated balloon (Concept Medical) was associated with a lower one-year rate of ...

Charing Cross (CX) Symposium co-chair Andrew Holden (Auckland City Hospital, Auckland, New Zealand) received the VIVA Foundation’s 2026 LIVE Award yesterday morning.

Mathews reported that the SELUTION4SFA trial successfully met the statistical threshold for superiority to plain balloon ...

Gore announced today the first patient enrolment in the IBE Plus pivotal study, a clinical trial evaluating the ...

Inquis Medical has announced the US commercial launch of its latest Aventus catheter, which is designed to provide physicians ...

Anders Wanhainen (Uppsala, Sweden) and colleagues put forward their argument for the selective use of paclitaxel-coated ...

Medtronic has received US Food and Drug Administration Breakthrough Device designation for its IN.PACT below-the-knee drug-coated balloon.

Save my name, email, and website in this browser for the next time I comment.